Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth

ErbB3, a member of the ErbB family of receptor tyrosine kinases, is a potent activator of phosphatidyl inositol-3 kinase (PI3K) and mTOR signaling, driving tumor cell survival and therapeutic resistance in breast cancers. In luminal breast cancers, ErbB3 upregulation following treatment with the ant...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncogene
Main Authors: Morrison, Meghan M., Williams, Michelle M., Vaught, David B., Hicks, Donna, Lim, Jiyeon, McKernan, Courtney, Aurisicchio, Luigi, Cennaro, Gilberto, Simion, Catalina, Sweeney, Colleen, Cook, Rebecca S.
Format: Artigo
Sprog:Inglês
Udgivet: 2015
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4703573/
https://ncbi.nlm.nih.gov/pubmed/26148232
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2015.169
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker